申请人:Oben Julius Enyoug
公开号:US20210154253A1
公开(公告)日:2021-05-27
Oxidative stress is implicated in neurodegenerative diseases such as Alzheimer's disease, and has been extensively studied as a potential target for therapeutic intervention. The present disclosure discloses a method for reducing free radicals in a mammal, the method comprises administering a composition containing an effective amount of
Baillonella toxisperma
extract to a mammal to reduce free radicals in the mammal. Specifically, the present disclosure demonstrates how extracts and flavonoids fractions of
Baillonella toxisperma
provide antioxidant and neuroprotective benefits and prevent oxidative stress in mammals.